同源重组
基因组不稳定性
癌变
DNA修复
非同源性末端接合
生物
DNA损伤
奥拉帕尼
同源染色体
癌症研究
DNA
化学
分子生物学
细胞生物学
遗传学
基因
聚合酶
聚ADP核糖聚合酶
作者
Aya Kurosawa,Shin Saito,Mikiko Sakurai,Machiko Shinozuka,Yuduki Someya,Noritaka Adachi
出处
期刊:FEBS Journal
[Wiley]
日期:2023-08-08
卷期号:290 (22): 5313-5321
被引量:1
摘要
Arsenic is a carcinogen that can cause skin, lung, and bladder cancer. While DNA double-strand breaks (DSBs) have been implicated in arsenic-induced carcinogenesis, the exact mechanism remains unclear. In this study, we performed genetic analysis to examine the impact of arsenic trioxide (As2 O3 ) on four different DSB repair pathways using the human pre-B cell line Nalm-6. Random integration analysis showed that As2 O3 does not negatively affect non-homologous end joining or polymerase theta-mediated end joining. In contrast, chromosomal DSB repair analysis revealed that As2 O3 decreases the efficiency of homologous recombination (HR) and, less prominently, single-strand annealing. Consistent with this finding, As2 O3 decreased gene-targeting efficiency, owing to a significant reduction in the frequency of HR-mediated targeted integration. To further verify the inhibitory effect of arsenic on HR, we examined cellular sensitivity to olaparib and camptothecin, which induce one-ended DSBs requiring HR for precise repair. Intriguingly, we found that As2 O3 significantly enhances sensitivity to those anticancer agents in HR-proficient cells. Our results suggest that arsenic-induced genomic instability is attributed to HR suppression, providing valuable insights into arsenic-associated carcinogenesis and therapeutic options.
科研通智能强力驱动
Strongly Powered by AbleSci AI